Initiator Alstra Microwave Peptide Synthesizer Tender - 148009801

Procurement Summary

Country: USA

Summary: Initiator Alstra Microwave Peptide Synthesizer, Usjp Configuration, Including an Alstra Tradein

Deadline: 31 Aug 2026

Posting Date: 27 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 148009801

Document Ref. No.: 75N98026Q01052

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Biotage for an Initiator+ Alstra™ Microwave Peptide Synthesizer, US/JP configuration, including an Alstra trade-in.
The Government intends to solicit from a single source in accordance with FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements, because the circumstances of this acquisition indicate that only one responsible source is capable of satisfying the Government's requirements.
Biotage is the only known responsible source capable of meeting the Government's specific technical and functional requirements. The Biotage Initiator+ Alstra peptide synthesizer incorporates proprietary technical capabilities that are integral to the Government's established peptide synthesis processes. These capabilities include Biotage's proprietary digital syringe pump reagent delivery system, robotically controlled dual-needle syringe technology, oscillatory mixing methodology, vacuum-pump-driven fluid transfer process, and integrated software specifically designed for the development, optimization, and execution of peptide synthesis protocols.
The Government's existing synthesis methods have been developed and validated using these proprietary features and depend upon their precise operation to maintain reproducibility, consistency, and continuity of ongoing research activities. Substitution with another manufacturer's system would require redevelopment and revalidation of established synthesis protocols and could result in significant delays, increased technical risk, potential inconsistencies in experimental results, and disruption to ongoing research activities.
Based on the Government's requirements, Biotage is the only known responsible source capable of providing a system that meets the required technical and functional requirements while maintaining compatibility with the Government's established peptide synthesis ...
Notice ID: 75n98026q01052

Department/Ind. Agency: health and human services, department of

Sub-tier: national institutes of health

Office: national institutes of health olao

Product Service Code: 6640 - laboratory equipment and supplies

NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing

Inactive Dates: sep 15, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice